Chemical Formula: C31H50O6
Chemical Formula C31H50O6
Found 114 metabolite its formula value is C31H50O6
DG(8:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)
DG(8:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/8:0/0:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))
DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/8:0)
DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)
DG(8:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/8:0/0:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))
DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/8:0)
DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)
DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/8:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))
DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/8:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)
DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/8:0/0:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))
DG(8:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/8:0)
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)
DG(8:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/8:0/0:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))
DG(8:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/8:0)
DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)
DG(8:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/8:0/0:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))
DG(8:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/8:0)
DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
2alpha,3beta,7beta-trihydroxy-11alpha-methoxyurs-12-en-28-oic acid
3beta,21beta,22beta,24-tetrahydroxy-20alpha-desmethyl-20alpha-methoxycarbonyl-olean-12-ene|kudzusapogenol B|kudzusapogenol B methylester|kuzusapogenol B-methyl ester
meliasenin S|methyl (13alpha,14beta,16beta,17alpha,24S)-16,24,25-trihydroxy-3-oxolanost-7-en-21-oate
3beta,11alpha,12,15alpha-tetrahydroxyurs-12-en-24-oic acid methyl ester
3beta,24-epoxy-2alpha,3alpha,6beta-trihydroxy-D:A-friedooleanan-29-oic acid methyl ester
methyl 1alpha,2alpha,3beta,23-tetrahydroxyolean-12-en-28-oate
2alpha,3beta,23-Trihydroxy-11beta-methoxy-urs-12-en-28-oic acid
(3R,5R,7R,8S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate
(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate
Punicesterone B
Punicesterone C
(3R,5R,7R,8S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate
(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-17-((R)-5-(oxetan-3-yl)pentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diyl diacetate
10,11-dihydroxy-9-(hydroxymethyl)-13-methoxy-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
methyl 1,10,11,13-tetrahydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
methyl (1r,2r,4as,6as,6br,10s,12ar)-1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
methyl (4as,6as,6br,8ar,9r,10r,11r,12s,12ar,12bs,14bs)-10,11,12-trihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
2α,3β,7β-trihydroxy-11α-methoxyurs-12-en-28-oicacid
{"Ingredient_id": "HBIN005219","Ingredient_name": "2\u03b1,3\u03b2,7\u03b2-trihydroxy-11\u03b1-methoxyurs-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C31H50O6","Ingredient_Smile": "CC1CCC2(CCC3(C(=CC(C4C3(C(CC5C4(CC(C(C5(C)C)O)O)C)O)C)OC)C2C1C)C)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21773","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}